PMID- 25130955 OWN - NLM STAT- MEDLINE DCOM- 20150106 LR - 20140913 IS - 2210-7762 (Print) VI - 207 IP - 6 DP - 2014 Jun TI - Extraskeletal myxoid chondrosarcoma with a t(9;16)(q22;p11.2) resulting in a NR4A3-FUS fusion. PG - 276-80 LID - S2210-7762(14)00138-0 [pii] LID - 10.1016/j.cancergen.2014.06.024 [doi] AB - Extraskeletal myxoid chondrosarcoma (EMC) is a rare neoplasm characterized by rearrangement of NR4A3. A t(9;22)(q22;q12), creating a fusion protein of EWSR1 and NR4A3, has been reported as a unique, recurring translocation in most cases. Reported variant translocations have resulted in fusion of NR4A3 with three other genes: TAF15, TCF12, and TFG. We report a case of EMC in a 59-year-old man who presented with a 6-month history of an enlarging mass in the proximal right thigh. The karyotype of fresh tissue from tumor taken at incisional biopsy revealed a t(9;16)(q22;p11.2). There was no evidence of an EWSR1 rearrangement by dual-color break-apart fluorescence in situ hybridization (FISH). Dual-color FISH probes revealed fusion of NR4A3 and FUS, a member of the TET family of genes, which includes EWSR1 and TAF15. Break-apart FISH probe results confirmed rearrangement of FUS. These findings show that a fusion product of FUS and NR4A3 may be an additional pathway to development of EMC. CI - Copyright (c) 2014 Elsevier Inc. All rights reserved. FAU - Broehm, Cory J AU - Broehm CJ AD - Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA. Electronic address: cbroehm@salud.unm.edu. FAU - Wu, Jin AU - Wu J AD - Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA. FAU - Gullapalli, Rama R AU - Gullapalli RR AD - Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA. FAU - Bocklage, Therese AU - Bocklage T AD - Department of Pathology, University of New Mexico School of Medicine, Albuquerque, NM, USA. LA - eng PT - Case Reports PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140626 PL - United States TA - Cancer Genet JT - Cancer genetics JID - 101539150 RN - 0 (DNA-Binding Proteins) RN - 0 (NR4A3 protein, human) RN - 0 (Oncogene Proteins, Fusion) RN - 0 (RNA-Binding Protein FUS) RN - 0 (Receptors, Steroid) RN - 0 (Receptors, Thyroid Hormone) RN - Chondrosarcoma, Extraskeletal Myxoid SB - IM MH - Chondrosarcoma/*genetics/pathology MH - Chromosomes, Human, Pair 16 MH - Chromosomes, Human, Pair 9 MH - Cytogenetics MH - DNA-Binding Proteins/*genetics MH - Humans MH - In Situ Hybridization, Fluorescence MH - Male MH - Middle Aged MH - Neoplasms, Connective and Soft Tissue/*genetics/pathology MH - Oncogene Proteins, Fusion/*genetics MH - RNA-Binding Protein FUS/*genetics MH - Receptors, Steroid/*genetics MH - Receptors, Thyroid Hormone/*genetics MH - Soft Tissue Neoplasms/*genetics/pathology MH - Translocation, Genetic OTO - NOTNLM OT - 16p11.2 OT - 9q22 OT - Extraskeletal myxoid chondrosarcoma OT - FUS OT - NR4A3 EDAT- 2014/08/19 06:00 MHDA- 2015/01/07 06:00 CRDT- 2014/08/19 06:00 PHST- 2014/04/03 00:00 [received] PHST- 2014/06/08 00:00 [revised] PHST- 2014/06/16 00:00 [accepted] PHST- 2014/08/19 06:00 [entrez] PHST- 2014/08/19 06:00 [pubmed] PHST- 2015/01/07 06:00 [medline] AID - S2210-7762(14)00138-0 [pii] AID - 10.1016/j.cancergen.2014.06.024 [doi] PST - ppublish SO - Cancer Genet. 2014 Jun;207(6):276-80. doi: 10.1016/j.cancergen.2014.06.024. Epub 2014 Jun 26.